Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101671376B details a novel 4-step synthesis of alkannin acetyl glucose. Discover cost-effective manufacturing and high-purity anti-tumor intermediates.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN101293889B details a novel glycosylation method for artemisinin. Enhance solubility and reduce toxicity with our scalable pharmaceutical intermediate manufacturing.
Novel hydrophilic surfactants derived from renewable chitin. Improved solubility and surface tension control for pharma and cosmetic applications via patented synthesis.
Patent CN104761599B details a novel synthesis route for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable manufacturing.
Patent CN114736315B details a novel one-pot synthesis for lentinan core fragments. This route eliminates toxic allyl protection, offering cost reduction in API manufacturing and reliable supply.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Patent CN111018928A reveals a novel 2-step synthesis for high-purity gastrodin hemihydrate, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN103122012B reveals a streamlined synthesis for fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN100488977C details a high-yield cytidine synthesis route offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN114891049B introduces stable o-alkynyl benzyl ether donors for high-efficiency glycoside synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.